Omri Amirav-Drory

Omri Amirav-Drory, Ph.D., is a seasoned biotech entrepreneur and investor currently serving as the General Partner at NFX Bio. With a background in both science and business operations, Omri has founded, scaled, and invested in leading techbio companies. As the former CEO of Genome Compiler, he led the company to a successful acquisition by Twist Bioscience, where he later served as Head of Corporate Development. Omri's subsequent role as Founding Partner at Tech.Bio saw him investing in and advising companies like Mammoth Biosciences and immunai, advocating for a future where Scientist-CEOs are the norm.